X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Bringing innovation to clinical trial design

By Richard Moscicki, M.D.  |    April 23, 2018
Clinical trials are critical to the discovery and development of innovative medicines that enable patients to live longer, healthier lives. As the biopharmaceutical industry works to identify,...   Read More

A new era in Alzheimer’s innovation

By Andrew Powaleny  |    April 19, 2018
After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds...   Read More

What is inter partes review and why does it matter?

By Nicole Longo  |    March 16, 2018
For more than three decades Hatch-Waxman (the Drug Price Competition and Patent Term Restoration Act of 1984) has encouraged innovation in biopharmaceutical development while at the same time...   Read More

ICYMI – Survey underscores daily burden of migraines

By Emma Van Hook  |    March 5, 2018
A new survey reveals the painful and disruptive reality of migraine for many patients, with many patients living with pain for nearly half of every month. The survey paints a picture of the...   Read More

New report shows 200 medicines in development for heart disease and stroke

By Andrew Powaleny  |    February 20, 2018
Cardiovascular disease, which includes heart disease and stroke, is the leading cause of death in the United States, accounting for one out of every three deaths. According to the American Heart...   Read More

Guest post: Help celebrate #ChampionsofScience: Nominate a pioneering researcher for the 2018 Dr. Paul Janssen Award for Biomedical Research

By Guest Contributor  |    January 29, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Innovation comes in many forms, including new and expanded uses of existing medicines

By Emma Van Hook  |    January 29, 2018
2017 was a record-breaking year for new drug approvals, with the U.S. Food and Drug Administration (FDA) approving 56 new drugs and biologics. But the innovation did not stop there. As the FDA...   Read More

New report and event examine the new era of vaccines

By Andrew Powaleny  |    November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...   Read More

A new era in cancer

By Andrew Powaleny  |    November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds...   Read More

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

By Andrew Powaleny  |    October 12, 2017
The rapid pace of scientific advances has helped usher in a new era of medicine for cancer patients over the last decade. This morning, the National Institutes of Health (NIH) took a significant...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates